Gene therapy company developing precision gene therapies for debilitating neurological disorders, with lead program in SCN1A+ Dravet syndrome using novel regulatory gene therapy.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.